Supplemental statement - recombinant influenza vaccines : Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023.: HP5-140/2022E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.913162&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | Supplemental statement - recombinant influenza vaccines : Canadian immunization guide chapter on influenza and statement on seasonal influenza vaccine for 2022-2023. |
| Variant title | Supplemental statement - quadrivalent recombinant influenza vaccines |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Déclaration supplémentaire - vaccins antigrippaux recombinants : chapitre sur la grippe du guide canadien d'immunisation et déclaration sur la vaccination antigrippale pour la saison 2022-2023. Cover title. On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220317." Issued also in HTML format. Includes bibliographical references (pages 51-54). |
| Publishing information | [Ottawa] : Public Health Agency of Canada = Agence de la santé publique du Canada, September 2022. ©2022 |
| Description | 1 online resource (57 pages) : illustration |
| ISBN | 9780660444864 |
| Catalogue number |
|
| Departmental catalogue number | 220317 |
| Subject terms | Influenza vaccines -- Canada. Influenza vaccines -- Government policy -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: